Paola Pedrelli, PhD is the Director Of Dual Diagnoses Studies at the Depression Clinical and Research Program. She is an Assistant in Psychology at Massachusetts General Hospital and an Assistant Professor in Psychiatry at Harvard Medical School. Her research focuses on investigating the etiology, assessment, and treatment of comorbid Affective Disorders and Alcohol Use Disorders (AUDs).
-
Artificial intelligence may be able to use data from wearable devices and smartphones to improve mental health care by providing real-time updates to clinicians. -
Can ketamine be used to decrease suicidality and risk of suicide after discharge from psychiatric hospitalization? -
College students reporting higher rates of weekly cannabis use were more likely to report psychotic symptoms. -
Four weeks of incentivized cannabis abstinence among adolescents and young adults was associated with an increase in both the frequency and amount of alcohol used.
-
Nearly half of these real-world patients with treatment-resistant depression elected to continue with IV ketamine because of perceived improvement of their depression and suicidal ideation. -
Augmentation with an oral analogue of allopregnanolone resulted in remission in menopausal women who failed antidepressant treatment.